increasing awareness in healthcare spending. Moreover, challenges faced by ophthalmic drugs market include
absence of health insurance in developing countries regarding eye diseases and lack of awareness among the
people regarding eye diseases and disorders in underdeveloped and developing countries. One of the key
opportunities for new entrants is securing drugs through a licensing agreement with major players such as
novartis and bayer, which could boost their growth over the forecast period.
Make an Enquiry: https://www.infiniumglobalresearch.com/reports/enquiry/165
Segment Covered
The report on global ophthalmic drugs market covers segments such as, disease condition and dispenses type. On
the basis of disease condition the global ophthalmic drugs market is categorized into allergy, glaucoma, dry eye
disorder and retinal disorder. On the basis of dispense type the global ophthalmic drugs market is categorized into
prescription and over the counter.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest
of the World. In this section the key trends and market size for each geography is provided over the period of
2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific
includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain,
and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as
it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth
owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at
a CAGR of x.x% over the period of 2017-2023.
Infinium Global Research